CNMD - CONMED Corporation logo

CNMD

CONMED Corporation

CONMED Corporation develops and manufactures medical devices for surgical procedures, specializing in orthopedic, general, and endoscopic surgery products. Its offerings include fixation systems, power tools, insufflation systems, and patient monitoring equipment, serving hospitals and healthcare facilities.

โš•๏ธ Healthcare NYSE Listed 1987 $ USD
$1,000 invested 30 years ago โ†’$5,406today

Score Overview

1 Year
Score
Net Growth20.07%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-0.14%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score5.7
Net Growth-9.67%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth35.81%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth285.28%
Net Trend50%
Net Income Consistency
Rev Growth79.77%
Rev Trend80%
Revenue Consistency
20 Years
Score4.9
Net Growth6x
Net Trend45%
Net Income Consistency
Rev Growth112.21%
Rev Trend70%
Revenue Consistency
30 Years
Score
Net Growth246.61%
Net Trend47%
Net Income Consistency
Rev Growth10x
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth51x
Net Trend51%
Net Income Consistency
Rev Growth109x
Rev Trend85%
Revenue Consistency

See the full market ranking โ†’

CONMED Corporation fundamental performance

Between 2020 and 2025, revenue grew from $ 862M to $ 1.37B and net income grew from $ 9M to $ 47M. Revenue increased in 4 of those 5 years; net income in 3.

Across CONMED Corporation's full reported history, from 1987 to 2025, revenue grew from $ 12M to $ 1.37B and net income grew from $ 1M to $ 47M. Revenue increased in 85% of the years measured; net income in 51%.

CONMED Corporation currently holds a 20-year HDB Score of 4.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 49.48โ€”
1 Year2025-08-12
$ 53.81-8.04%
5 Years2021-08-12
$ 118.72-58.32%
10 Years2016-08-12
$ 35.0441.21%
20 Years2006-08-11
$ 16.20205.42%
30 Years1996-08-12
$ 9.15440.59%
All Time1987-07-23
$ 1.9125x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 1.37B$ 56M$ 37M
2025$ 1.37B$ 47M$ 40M
2024$ 1.30B$ 132M$ 24M
2023$ 1.24B$ 64M$ 24M
2022$ 1.04B-$ 80M$ 28M
2021$ 1.01B$ 62M$ 20M
2020$ 862M$ 9M$ 27M
2019$ 955M$ 28M$ 25M
2018$ 859M$ 40M$ 17M
2017$ 796M$ 55M$ 32M
2016$ 763M$ 14M$ 27M
2015$ 719M$ 30M$ 72M
2014$ 734M$ 32M$ 66M
2013$ 756M$ 35M$ 54M
2012$ 767M$ 40M$ 23M
2011$ 725M$ 752K$ 26M
2010$ 713M$ 30M$ 12M
2009$ 694M$ 12M$ 9M
2008$ 742M$ 44M$ 11M
2007$ 694M$ 41M$ 11M
2006$ 646M-$ 12M$ 3M
2005$ 617M$ 31M$ 3M
2004$ 558M$ 33M$ 4M
2003$ 497M$ 32M$ 5M
2002$ 453M$ 34M$ 5M
2001$ 428M$ 24M$ 1M
2000$ 392M$ 19M$ 3M
1999$ 372M$ 27M$ 3M
1998$ 336M$ 17M$ 5M
1997$ 138M-$ 7M$ 13M
1996$ 125M$ 16M$ 20M
1995$ 99M$ 10M$ 1M
1994$ 71M$ 5M
1993$ 53M-$ 1M$ 2M
1992$ 42M$ 4M$ 7M
1991$ 38M$ 3M$ 4M
1990$ 31M$ 2M$ 200K
1989$ 19M-$ 300K$ 300K
1988$ 14M$ 800K$ 2M
IPO1987$ 12M$ 1M$ 4M

Explore beyond CNMD

You're looking at CONMED Corporation. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies